Dublin, March 07, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/z958f7/hernia_mesh) has announced the addition of the "Hernia Mesh Devices Market - Global Forecast to 2020" report to their offering.
The global hernia mesh devices market is expected to grow at a CAGR of 2.0% from 2015 to 2020 to reach a market size of USD 3.73 Billion by 2020.
According to information available from hospital morbidity database (HMDB), HCUP, and others, it is estimated that around 10.9 million hernia repair surgeries were performed globally in 2014, and this number is projected to reach -12 million by 2020, increasing at a compound annual growth rate of 1.8% from 2015 to 2020.
This report studies inguinal, umbilical, hiatal, femoral, incisional, and other types of hernia. Inguinal hernia is the most common type and constituted 55.8% of the total number of hernia surgeries in 2014, followed by incisional/ventral hernia repair surgeries at 17.2%. Femoral hernia occurs very rarely and accounted for just 1.5% of the total hernia repair surgeries in 2014.
Obesity, excessive physical activity, and age are the main factors responsible for the occurrence of hernia. Of the 10.9 million hernia surgeries globally in 2014, majority of surgeries were performed in APAC, followed by Europe and Americas. However, since the price of mesh constitutes the major portion of the surgery cost, majority of the patient pool from underdeveloped and developing countries either don't take treatment or choose suture over mesh.
Due to this, in terms of total hernia repair surgeries performed using mesh, the Americas accounted for majority of surgeries. However, due to its huge patient pool, APAC contributed largest share in terms of volume of the total hernia surgeries, followed by Europe and the Americas, in 2014.
The Americas led the market in terms of volume or consumption of hernia mesh implants, followed by Europe and APAC. In terms of revenue, America holds the largest share, followed by Europe and APAC in 2014. The scenario is not expected to change much, although APAC is expected to grab some share from Europe and America due to betterment of healthcare infrastructure and increasing awareness about hernia repair surgeries in this region.
Companies Mentioned:
- Atrium
- B. Braun Melsungen Ag
- C.R. Bard Inc.
- Ethicon, Inc.
- Lifecell Corporation
- Medtronic
- W.L. Gore & Associates
For more information visit http://www.researchandmarkets.com/research/z958f7/hernia_mesh
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



